90R1840 AB-D
 
  By: Menéndez S.B. No. 136
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to Medicaid coverage and reimbursement for seizure
  detection devices and a public awareness campaign related to those
  devices.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter B, Chapter 32, Human Resources Code,
  is amended by adding Section 32.03142 to read as follows:
         Sec. 32.03142.  SEIZURE DETECTION DEVICES; AWARENESS
  CAMPAIGN.  (a)  In this section, "seizure detection device" means a
  telemonitoring device approved by the United States Food and Drug
  Administration, including any related service or subscription that
  supports the device's prescribed use, that:
               (1)  provides ongoing patient monitoring and alert
  services to detect seizure activity;
               (2)  transmits notice of a patient's seizure activity
  to a caregiver for appropriate medical response; or
               (3)  collects data on a patient's seizure activity for a
  health care provider to diagnose or appropriately treat a health
  care condition causing the seizure activity.
         (b)  The commission shall ensure medical assistance
  reimbursement is provided to cover in full the cost of a seizure
  detection device for a medical assistance recipient if the
  recipient's health care provider determines the device:
               (1)  is medically appropriate based on the recipient's
  medical condition or status; and
               (2)  will likely:
                     (A)  assist in reducing bodily harm to or death of
  the recipient as a result of a seizure; or
                     (B)  provide data to the health care provider
  necessary to appropriately diagnose or treat the recipient's health
  condition causing the seizure activity.
         (c)  For purposes of providing reimbursement under this
  section, a seizure detection device is durable medical equipment
  and the commission shall ensure the reimbursement rate for related
  service and subscription fees is at least equal to the
  reimbursement rate for home telemonitoring services under
  Subchapter F, Chapter 548, Government Code.
         (d)  The commission shall conduct a biennial review of the
  seizure detection devices covered under this section and update the
  list of covered devices as necessary based on technology
  advancements and guidance issued by the United States Food and Drug
  Administration.
         (e)  The commission shall implement a statewide public
  awareness campaign to educate health care providers, medical
  assistance recipients, and the general public on the availability,
  benefits, and coverage of seizure detection devices and related
  services and subscriptions under this section.
         (f)  The campaign under Subsection (e) must be designed to:
               (1)  clearly inform health care providers and
  recipients that the full cost of seizure detection devices and
  related services and subscriptions for the device's use are
  reimbursable under this section;
               (2)  emphasize the ability of seizure detection devices
  to help reduce the risk of seizure-related injuries and enhance the
  quality of life for individuals living with epilepsy and their
  families;
               (3)  provide essential information on sudden,
  unexpected death from epilepsy, including the associated risks and
  how seizure detection devices reduce the risk of sudden, unexpected
  death from epilepsy by enabling timely intervention during
  seizures; and
               (4)  provide resources for further education and
  support for those at risk of sudden, unexpected death from
  epilepsy.
         SECTION 2.  If before implementing any provision of this Act
  a state agency determines that a waiver or authorization from a
  federal agency is necessary for implementation of that provision,
  the agency affected by the provision shall request the waiver or
  authorization and may delay implementing that provision until the
  waiver or authorization is granted.
         SECTION 3.  This Act takes effect September 1, 2027.